The groundbreaking therapy of this peptide represents a major development in the management of type 2 diabetes. Different to existing therapies, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide619558.mdkblog.com/48182642/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment